EMPLOYMENT
AGREEMENT


 


This
SEVEN (7) MONTH EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 29th day of DECEMBER,
2017, between NOVO INTEGRATED SCIENCES, INC., a Nevada Corporation (the “Company”) located at 11120 NE
2nd Street, Suite 200, Bellevue, Washington 98004, and CHRISTOPHER DAVID, an individual residing in Washington
State, currently acting as the Companies’ President and Director (the “Executive”).


 


RECITALS


 


A.
The Company is a Nevada, small-reporting corporation, that develops and provides both products and services in the healthcare
and medical cannabis sector.


 


B.
The Executive is an individual who has knowledge and abilities useful to the Company and who is currently serving the Company
as its President and Director.


 


C.
The Company desires to provide certain compensation to Mr. David for services to be performed by Mr. David, as President of the
Company, which allows Mr. David to remain fulfilling the roles and responsibilities as the company’s President, a position
he has filled for the Company since May 10, 2015.


 


D.
This seven (7) month Employment Agreement replaces the previous six (6) month Employment Agreement, dated July 12, 2017 between
the Company and Mr. David with all terms and conditions of the July 12, 2017 six (6) month Employment Agreement having been met
and Mr. David’s relationship with the Company being in good standing.


 


NOW,
THEREFORE, in consideration of the mutual promises between the parties, the parties agree as follows:


 


1.
Recitals. The recitals as stated in the preamble are true and correct and incorporated herein by reference.


 


2.
Term of Agreement. This Agreement shall be effective as of January 1, 2018 and shall continue until July 30, 2018 (“Termination
Date”), subject to the termination provisions contained in paragraph 6.


 


3.
Duties. During the term of this Agreement, the Executive shall devote a sufficient amount of Executive’s time, skill, and
experience to manage the Company as its President, which is both an Executive Management and a Corporate Officer position. The
Executive shall have all the usual powers of a President. This Agreement is entered into solely for the purpose of providing specific
compensation to Executive for the provision of future services to the Company for the period of the Term. The terms and conditions
of Executive’s performance of his duties shall be subject to the Board’s supervision at all times and such terms are
not addressed in this Agreement. The Parties shall maintain an open relationship with clear communication and clear determination
of duties.


 




    	 	 	 



    	P a g e | 2
	 



    

 


4.
Compensation. At commencement of the Term of this Agreement, the Company shall pay to Executive the following incentive compensation:


 


	 	(a)	A
    monthly salary of US$8,000;
	 	 	 
	 	(b)	The
    Executive shall be granted a Five-year (5) option for the purchase of two million (2,000,000) shares of the Company’s
    restricted Rule 144 common stock at a per option price of forty-two cents (US$0.42) with a grant date of December 29, 2017,
    a vest date of December 29, 2017 and an expiration date of December 29, 2017 (5-years from grant date), without further action.
    In the event that the number of authorized shares is altered, pursuant to stock splits, initial public offerings, or other
    activity, all of the shares granted to the Executive hereunder shall be adjusted proportionately.


 


5.
Executive Benefits. The Executive is entitled to such other Executive Benefits as shall be determined by the Board, from time
to time.


 


6.
Termination. The Compensation covered by this Agreement is for the Executive’s future services to the Company for the Term.
This Agreement shall be terminated as of the end of the defined term, unless the parties renew the same in writing. The Company
may terminate Executive at any time, with or without cause, provided however, if the Executive is terminated without cause:


 


	 	(a)	the
    stock option compensation to be paid hereunder shall be deemed granted and fully vested at the time of this seven (7) month
    Employment Agreement and is not subject to revocation or return.
	 	 	 
	 	(b)	The
    monthly salary will still be owed to the Executive for the duration of the defined seven (7) month term, through July 30,
    2018.


 


The
term “cause” shall mean the Executive must have (i) been willful, gross or persistent in Executive’s inattention
to Executive’s duties or the Executive committed acts which constitute willful or gross misconduct and, after written notice
of the same has been given to the Executive and he has been given an opportunity to cure the same within thirty (30) days after
such notice; or (ii) found guilty of having committed actual fraud against the Company.


 


7.
Notice. Any notice required or permitted to be given under this Agreement shall be sufficient if in writing and if sent by certified
mail to the Executive’s address listed below, unless written notice of a change of address has been provided to the Company:


 


Christopher
David


______________


______________


 




    	 	 	 



    	P a g e | 3
	 



    

 





8.
Miscellaneous. Failure of either party to assert any of its rights under this Agreement shall not constitute a waiver of its rights.
The waiver by any party of a breach of any provisions of this Agreement shall not operate or be construed as a waiver of any subsequent
breach by any party. This Agreement shall inure to the benefit of, and be binding on, the parties and their successors, heirs,
personal representatives, and assigns. This instrument contains the entire agreement of the parties. It may not be changed orally
but only by an agreement in writing signed by any party against whom enforcement of any waiver, change, modification, extension,
or discharge is sought. If any provisions of this Agreement are declared invalid and unenforceable, the remainder of this Agreement
shall continue in full force and effect. This Agreement shall be construed, interpreted, governed, and enforced in and under the
laws of the state of Washington except as otherwise provided in this Agreement. Paragraph headings are inserted only for convenience
and are not to be construed as part of this Agreement or a limitation of the scope of the particular paragraph to which they refer.


 


9.
Attorneys’ Fees. In the event that either Party hereto commences litigation against the other to enforce such party’s
rights hereunder, the prevailing party shall be entitled to recover all costs, expenses and fees, including reasonable attorneys’
fees (including in-house counsel), paralegals’, fees, and legal assistants’ fees through all appeals.


 


IN
WITNESS WHEREOF, the parties hereto have executed this Agreement the day and year first above written.


 


	“Company”	 	“Executive”
	NOVO
    INTEGRATED SCIENCES, INC.	 	Christopher
    David
	 	 	 	 	 
	 	/s/
    Pierre Dalcourt	 	 	/s/
    Christopher David
	By:	Pierre
    Dalcourt, Board Chairman	 	By:
    	Christopher
    David